| Sep 13, 2012
Genes make us who we are — in sickness and in health. We get our genetic makeup from our parents, of course, but in the future, we might be getting genes from our doctors too. Imagine your doctor promising to cure your cancer or heart disease by...
| Aug 31, 2011
| 9:43 AM
NEW YORK (Reuters Health) - A new study adds to evidence that skin patches offer a safer alternative to pills for women who want to treat their menopausal symptoms with hormones.
The study, of 54,000 women who used hormone replacement therapy (HRT),...
| Sep 20, 2011
| 8:52 AM
ZURICH (Reuters) - Doctors and investors at a cancer conference starting on Friday will be keen to find out more on the effectiveness of two promising new breast cancer drugs from Swiss drugmakers Roche and Novartis.
Roche's T-DM1 and Novartis's Afinitor...
| Sep 25, 2011
| 3:31 AM
STOCKHOLM (Reuters) - Roche's bone strengthening drug Boniva is as good for pain relief as single dose radiotherapy in patients whose prostate cancer has spread to their bones, according to data from a late-stage trial released on Sunday.
| Sep 25, 2011
| 8:21 AM
STOCKHOLM (Reuters) - Novartis's bone drug Zometa extended survival in older breast cancer patients but failed to improve disease-free survival among younger women patients in a large-scale clinical trial, researchers said on Sunday.
| Sep 29, 2010
British scientists have found the first direct evidence that attention-deficit/hyperactivity disorder is a genetic disorder and say their research could eventually lead to better treatments for the condition.
Researchers who scanned the gene maps of more...
| Sep 22, 2010
| 12:04 PM
A failed anti-rejection drug got a new purpose and a new lease on commercial life Wednesday as the Food and Drug Administration approved the medication fingolimod -- to be marketed as Gilenya -- to slow the progression of disability in multiple...
| Jul 15, 2012
| 8:05 AM
CHICAGO (Reuters) - At an ill-fated press conference in 1984, U.S. Health and Human Services Secretary Margaret Heckler boldly predicted an effective AIDS vaccine would be available within just two years.
But a string of failed attempts - punctuated by a...
| May 22, 2012
| 11:57 AM
NEW YORK (Reuters Health) - Results from a large U.S. study suggest women who regularly exercise vigorously, including runners and aerobics buffs, may be less likely to get psoriasis than less-active women.
Researchers have known that people who are...
| Oct 25, 2011
| 2:21 PM
NEW YORK (Reuters Health) - One class of drugs used to prevent wheezing and shortness of breath in people with asthma may increase kids' risk of being hospitalized for an asthma attack, according to a new analysis from the U.S. Food and Drug...
| Jan 17, 2011
| 10:59 AM
The U.S. Attorneyâs Office for the Eastern District of Pennsylvania announced Thursday that it has collected nearly $4.4 billion in civil penalties since 2004. While the rules for disbursing those payments between state and federal agencies make it...
| Apr 21, 2011
| 4:36 PM
Like sands through the hourglass, daytime soap operas are falling off the TV grid. The recent demise started in 2007 with the cancellation of “Passions” on NBC (and later on DirecTV). Two years later, CBS nixed “The Guiding Light”...